ConductScience.org, home

Paper36074333

Advances in insulin therapy from discovery to β-cell replacement.

Sakurai T and 3 others. J Diabetes Investig, 2023. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Advances in insulin therapy from discovery to β-cell replacement. Papers, record 36074333. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36074333

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advances in insulin therapy from discovery to β-cell replacement.
PubMed
Journal
J Diabetes Investig
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.43
iCite
Revised in PubMed
2023-01-11
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes MellitusMajor topic
Diabetes Mellitus, Type 1Major topic
Animals
Cattle
Humans
Swine
Insulin
Recombinant Proteins

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
21K19504Japan Society for the Promotion of SciencePubMed

Source PubMed

Download CSV of grants

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134861146Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes.Cell Stem Cell2021https://conductscience.org/library/papers/34861146PubMed
326279320
Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation.
J Diabetes Complications2015https://conductscience.org/library/papers/26279320PubMed
435818819β cell replacement therapy for the cure of diabetes.J Diabetes Investig2022https://conductscience.org/library/papers/35818819PubMed
5503234Nucleotide sequence of a cDNA clone encoding human preproinsulin.Nature1979https://conductscience.org/library/papers/503234PubMed
635532954Comparison of the clinical effects of intermittently scanned and real-time continuous glucose monitoring in children and adolescents with type 1 diabetes: A retrospective cohort study.J Diabetes Investig2022https://conductscience.org/library/papers/35532954PubMed
733084417Can Smart Pens Help Improve Diabetes Management?J Diabetes Sci Technol2022https://conductscience.org/library/papers/33084417PubMed
832562376
Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal-bolus insulin therapy: An open label, prospective, multicenter trial in Japan.
J Diabetes Investig2021https://conductscience.org/library/papers/32562376PubMed
1034551215Comparisons of efficacy and safety in insulin glargine and lixisenatide plus glulisine combination therapy with multiple daily injection therapy in Japanese patients with type 2 diabetes.J Diabetes Investig2022https://conductscience.org/library/papers/34551215PubMed
1133595901
Efficacy and safety of the fixed-ratio combination of insulin degludec and liraglutide by baseline glycated hemoglobin, body mass index and age in Japanese individuals with type 2 diabetes: A subgroup analysis of two phase III trials.
J Diabetes Investig2021https://conductscience.org/library/papers/33595901PubMed
1232654418Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell.J Diabetes Investig2021https://conductscience.org/library/papers/32654418PubMed
1327267268Efficacy of lixisenatide in patients with type 2 diabetes: A post hoc analysis of patients with diverse β-cell function in the GetGoal-M and GetGoal-S trials.J Diabetes Complications2016https://conductscience.org/library/papers/27267268PubMed
1432323451Association of glucagon-like peptide-1 receptor-targeted imaging probe with in vivo glucagon-like peptide-1 receptor agonist glucose-lowering effects.J Diabetes Investig2020https://conductscience.org/library/papers/32323451PubMed
1529106046
Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation.
J Diabetes Investig2018https://conductscience.org/library/papers/29106046PubMed
1625220191Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis.Lancet2014https://conductscience.org/library/papers/25220191PubMed
17460416Semi-synthesis of human insulin by trypsin-catalysed replacement of Ala-B30 by Thr in porcine insulin.Nature1979https://conductscience.org/library/papers/460416PubMed
2034022121Effects of glucagon-like peptide-1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study.J Diabetes Investig2021https://conductscience.org/library/papers/34022121PubMed
2135145326MYCL-mediated reprogramming expands pancreatic insulin-producing cells.Nat Metab2022https://conductscience.org/library/papers/35145326PubMed
2235727409Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes.Curr Cardiol Rep2022https://conductscience.org/library/papers/35727409PubMed
2333945227iGlarLixi reduces residual hyperglycemia in Japanese patients with type 2 diabetes uncontrolled on basal insulin: A post-hoc analysis of the LixiLan JP-L trial.J Diabetes Investig2021https://conductscience.org/library/papers/33945227PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
39877437Differentiation, reduction, and proliferation of pancreatic β-cells and their regulatory factors.Diabetol Int2025https://conductscience.org/library/papers/39877437PubMed
39575893Toward a cure for diabetes: iPSC and ESC-derived islet cell transplantation trials.J Diabetes Investig2025https://conductscience.org/library/papers/39575893PubMed
38571372An update of contemporary insulin therapy.J Diabetes Investig2024https://conductscience.org/library/papers/38571372PubMed
36906290Noninvasive quantitative evaluation of viable islet grafts using 111 In-exendin-4 SPECT/CT.FASEB J2023https://conductscience.org/library/papers/36906290PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GCG2641PubTator's text mininghttps://conductscience.org/library/genes/2641NCBI Gene
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
MYCL4610PubTator's text mininghttps://conductscience.org/library/genes/4610NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36074333

GET https://conductscience.org/api/papers/v1/36074333/authors